Ann Salm

About Ann Salm

Senior Medical Affairs leader with national responsibility for directing field medical strategy across infectious disease and immunology diagnostic portfolios. Proven track record shaping KOL engagement frameworks, advancing evidence generation initiatives, and aligning diagnostic innovation with reimbursement strategy and public health priorities to drive measurable clinical and organizational impact.Provide strategic field medical leadership across national MSL initiatives supporting molecular infectious disease panels, transplant and autoimmune diagnostics, and therapeutic monoclonal antibody monitoring. Lead high level scientific engagement through advisory boards, executive exchange, speaker development, and research collaborations with academic institutions, health systems, and integrated delivery networks, strengthening long term partnerships and elevating clinical credibility.Direct comprehensive evidence generation and publication strategy focused on antimicrobial resistance surveillance, tuberculosis blood testing, SARS CoV 2 biomarkers, and outpatient resistance patterns. Publish abstracts and peer reviewed research supporting diagnostic stewardship, health system optimization, and public health surveillance objectives.Partner cross functionally with medical affairs, research and development, commercial, and market access teams to reinforce innovation pipelines, optimize reimbursement positioning, and enhance payer engagement strategy. Lean Six Sigma Green Belt with strong expertise in regulatory frameworks, healthcare operations, and quality driven laboratory environments.Scientific expertise includes infectious disease, immunology, molecular diagnostics, antimicrobial resistance, transplant testing, autoimmune diagnostics, and public health response.

Experience

1. Director, Msl Infectious Disease & Immunology

   Quest Diagnostics

   Jan 2017 — Present · US

   National field medical leader supporting infectious disease and immunology diagnostic portfolios across the United States and Quest Global Diagnostics Network (GDN).• Lead national KOL engagement strategy including advisory boards, executive scientific exchange, speaker training, and consultancy partnerships• Partner cross-functionally with medical affairs, R&D, commercial, and market access to enhance innovation and reimbursement strategies• Contributed to national pandemic response initiatives through biomarker education and SARS-CoV-2 clinical guidance development• Directed research initiatives and publication strategy focused on antimicrobial resistance, TB blood testing, COVID-19 biomarkers, and urinary E. coli resistance trends• Engaged payers and health systems to validate clinical utility and outcomes for molecular infectious disease panels

Education

• Marian University of Fond du Lac

  B.S., Biology

  1991 — 1995

• Marian University

  PhD Leadership Studies, Undergraduate Research Mentorship; Translational Medicine-Sepsis/Procalcitonin

  2010 — 2015

• University of Wisconsin-Madison

  M.S., Biotechnology

  2007 — 2009

• School for Field Studies

  Research, Queensland Australia: Tropical Reforestation

  1994 — 1994

• Michigan State University

  Molecular Diagnostic Certificate, Professional Certificate: Molecular Diagnostics

  2006 — 2007

Skills

• Project Management
• Public Health
• Genetics
• Good Clinical Practice (Gcp)
• Infectious Disease Diagnostics
• Leadership
• Life Sciences
• Epidemiology
• Teaching
• Medical Devices
• Clinical Research
• Biology
• Microsoft Office
• Laboratory
• Data Analysis
• Research
• Six Sigma
• Rt-Pcr
• Molecular Biology
• Science
• Pcr
• Process Improvement
• Elisa
• Microbiology
• Qpcr
• Training
• Management
• Team Building
• Biotechnology
• Strategic Planning
• Healthcare
• Customer Service
• Higher Education
• Lifesciences
• Organizational Leadership
• Clinical Microbiology
• Good Laboratory Practice (Glp)
• U.s. Food and Drug Administration (Fda)
• Biochemistry
• Medical Diagnostics